Fetal exposure to Dihydroergotamine (medical condition): There is evidence to indicate that exposure to Dihydroergotamine (a migraine drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
See also:
Dihydroergotamine - Teratogenic Agent:
»Introduction: Dihydroergotamine - Teratogenic Agent
»Symptoms of Dihydroergotamine - Teratogenic Agent
These medical condition or symptom topics may be relevant to medical information for Fetal exposure to Dihydroergotamine:
Fetal exposure to Dihydroergotamine: Another name for Dihydroergotamine - Teratogenic Agent (or close medical condition association).
»Introduction: Dihydroergotamine - Teratogenic Agent
»Symptoms of Dihydroergotamine - Teratogenic Agent
Some of the symptoms of Fetal exposure to Dihydroergotamine incude:
Search to find out more about Fetal exposure to Dihydroergotamine:
|
What do you think about the features of this website? Take our user survey and have your say:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
